Massachusetts Financial Services’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
Other funds holding KNSA
RHJA
PCM
Massachusetts Financial Services's KNSA Position: Q2 2026 in Review
Massachusetts Financial Services reduced its Kiniksa Pharmaceuticals (KNSA) stake by 1.5% in Q2 2026, selling an estimated $346K and leaving 431,324 shares worth $27.6M. The position accounts for 0.01% of the portfolio, ranked #607.
Massachusetts Financial Services first reported a position in KNSA in Q1 2023 and has held it in 14 quarters since. 94 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.
- Massachusetts Financial Services held 431,324 shares of Kiniksa Pharmaceuticals worth $27.6M as of Q2 2026.
- Massachusetts Financial Services sold 6,678 Kiniksa Pharmaceuticals shares in Q2 2026, an estimated $346K.
- Kiniksa Pharmaceuticals made up 0.01% of Massachusetts Financial Services's portfolio in Q2 2026, its #607 holding.
- Massachusetts Financial Services first reported a position in Kiniksa Pharmaceuticals in Q1 2023 and has held it in 14 quarters since.
- 94 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.
Based on Massachusetts Financial Services's 13F filing for Q2 2026, filed 3 Aug 2026.